Skip to main content

Global Animal Vaccines Markets, 2021-2028: Breakdown By Poultry, Aqua, Ruminants, Companion, Canine, Feline, Swine

DUBLIN, Nov. 15, 2021 /PRNewswire/ -- The "Animal Vaccines Market 2021 - 2028" report has been added to ResearchAndMarkets.
  • Author:
  • Publish date:

DUBLIN, Nov. 15, 2021 /PRNewswire/ -- The "Animal Vaccines Market 2021 - 2028" report has been added to's offering.

The global animal vaccines market size is expected to reach $16.27 billion by 2028The increasing cases of zoonotic diseases and the rising number of infectious diseases in different types of meat that are slowing the growth of the industry will be the main factors responsible for the development of the global market. The emergence of modern recombinant injections and the investment by governments for mass immunization programs are anticipated to fuel the market growth further.Zoonotic diseases have been shared across the globe in the past few decades, and more than half of the emerging infectious diseases worldwide are originated from pets. Many diseases have been transmitted from pets to humans, such as Swine flu. Hence, it is necessary to vaccinate food and pets to prevent any such disease from spreading in the coming years.The introduction of new and innovative technologies such as recombinant serums will develop innovative products in the coming years. These inoculations can overcome the limitations of conventional medicines and hence will be widely adopted. For instance, in April 2021, ICAR-CIBA launched a recombinant vaccine CIBA-Nodavac-R against nervous necrosis virus (NNV), which affects marine, brackish water, and freshwater fish that results in 100 % mortality in early juvenile and larval stages.Numerous developments are taking place in the market with the launch of many medications and acqisitions, funding, and collaborations. Zoetis launched the porcine vaccine CircoMax Myco in May 2021, the only vaccine for the protection against Mycoplasma hyopneumoniae and PCV2. Applied LifeSciences & Systems (ALSS) raised Usd 7 million in recent funding in May 2021 to automate poultry vaccination systems. Market participants include

  • Biogenesis Bago
  • Boehringer Ingelheim International GmbH
  • Ceva
  • Elanco
  • Indian Immunologicals Ltd.
  • Intas Pharmaceuticals Ltd.
  • Merck & Co. Inc.
  • Neogen Corporation
  • Ourofino Saude Animal
  • Phibro Animal Health Corporation
  • Virbac
  • Zoetis

Key Topics Covered: 1. Introduction 2. Executive Summary 3. Research Methodology 4. Animal Vaccines Market Insights4.1. Animal Vaccines - Industry snapshot4.2. Animal Vaccines Market Dynamics4.2.1. Drivers and Opportunities4.2.1.1. Outbreak of livestock diseases4.2.1.2. Innovations in vaccine research4.2.2. Restraints and Challenges4.2.2.1. Associated side effects4.3. Porter's Five Forces Analysis4.4. PESTLE Analysis4.5. Animal Vaccines Market Industry trends4.6. COVID-19 Impact Analysis 5. Animal Vaccines Market Assessment by Product5.1. Key Findings5.2. Introduction5.2.1. Global Animal Vaccines Market, By Product, 2016 - 2028 (USD Million)5.3. Attenuated Live Vaccines5.4. Inactivated Vaccines5.5. Subunit Vaccines5.6. DNA Vaccines5.7. Recombinant Vaccines 6. Global Animal Vaccines Market, by Animal Type6.1. Key Findings6.2. Introduction6.3. Poultry6.3.1. Global Poultry Vaccines Market by Disease Type, By Region, 2016 - 2028 (USD Million)6.3.2. Infectious bronchitis6.3.3. Avian influenza6.3.4. Marek's disease6.3.5. Newcastle disease6.3.6. Salmonella6.4. Aqua6.4.1. Global Aqua Vaccines Market by Disease Type, By Region, 2016 - 2028 (USD Million)6.4.2. Bacterial6.4.3. Viral6.5. Ruminants6.5.1. Global Ruminants Vaccines Market by Disease Type, By Region, 2016 - 2028 (USD Million)6.5.2. Foot & Mouth Disease (FMD)6.5.3. Lumpy skin6.5.4. Rotavirus6.5.5. Coronavirus6.5.6. Coli6.6. Companion6.6.1. Global Companion Vaccines Market by Disease Type, By Region, 2016 - 2028 (USD Million)6.6.2. Canine6.6.2.1. Distemper6.6.2.2. Kennel cough6.6.2.3. Parvovirus6.6.2.4. Canine herpes6.6.2.5. Lyme disease6.6.2.6. Rabies6.6.3. Feline6.6.3.1. Rhinotracheitis6.6.3.2. Calicivirus6.6.3.3. Coronavirus6.6.3.4. Panleukopenia6.6.3.5. Rabies6.7. Swine6.7.1. Global Swine Vaccines Market, by Disease Type, by Region, 2016 - 2028 (USD Million)6.7.2. Swine influenza6.7.3. Classical Swine Fever (CSF)6.7.4. Porcine Parvovirus (PPV)6.7.5. Porcine Circovirus Type 2 (PCV2)6.7.6. M. Hyo6.7.7. Actinobacillus Pleuropneumoniae6.7.8. PRRS6.7.9. Foot & mouth disease 6.7.10. Pseudorabies 6.7.11. PEDV (coronavirus) 7. Animal Vaccines Market Assessment by Geography7.1. Key findings7.2. Introduction7.2.1. Animal Vaccines Market Assessment, By Geography, 2016 - 2028 (USD Million) 8. Competitive Landscape8.1. Expansion and Acquisition Analysis8.1.1. Expansion8.1.2. Acquisitions8.2. Partnerships/Collaborations/Agreements/Exhibitions 9. Company Profiles9.1. Company Overview9.2. Financial Performance9.3. Product Benchmarking9.4. Recent Development

For more information about this report visit

Media Contact:

Research and Markets Laura Wood, Senior Manager For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

View original content:

SOURCE Research and Markets